登錄 | 註冊
我要路演
紀要

Abbott Laboratories (ABT) Q1 2023 Earnings Call

2023-04-20 00:56

Abbott Laboratories (NYSE:ABT) Q1 2023 Earnings Conference Call April 19, 2023 9:00 AM ET

Company Participants

Scott Leinenweber - Vice President, Investor Relations

Robert Ford - Chairman and Chief Executive Officer

Bob Funck - Executive Vice President, Finance and Chief Financial Officer

Conference Call Participants

Larry Biegelsen - Wells Fargo

Joshua Jennings - Cowen

Robbie Marcus - JPMorgan

Rick Wise - Stifel

Vijay Kumar - Evercore ISI

Joanne Wuensch - Citi

Danielle Antalffy - UBS

Matt Miksic - Barclays

Operator

Good morning and thank you for standing by. Welcome to Abbott's First Quarter 2023 Earnings Conference Call. All participants will be able to listen-only until the question and answer portion of this call. [Operator Instructions] This call is being recorded by Abbott. With the exception of any participants' questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's expressed written permission.

I would now like to introduce Mr. Scott Leinenweber, Vice President, Investor Relations, Licensing and Acquisitions.

Scott Leinenweber

Good morning and thank you for joining us. With me today are Robert Ford, Chairman and Chief Executive Officer; and Bob Funck, Executive Vice President, Finance and Chief Financial Officer. Robert and Bob will provide opening remarks. Following their comments, we'll take your questions.

Before we get started, some statements made today maybe forward-looking for purposes of the Private Securities Litigation Reform Act of 1995, including the expected financial results for 2023. Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.

Economic, competitive, governmental, technological and other factors that may affect Abbott's operations are discussed in Item 1A, Risk Factors to our annual report on Form 10-K for the year ended

雅培
雅培公司(ABT.US)2023年第一季度業績電話會
開始時間
2023-04-20 00:56
會議性質
業績會路演
會議形式
線上會議